HSBC Holdings
RYTM icon

HSBC Holdings’s Rhythm Pharmaceuticals RYTM Stock Holding History

HSBC Holdings’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,307
Closed -$1.22M – 3163
2026
Q1 		$1.22M Buy
+14,307
New +$1.39M ﹤0.01% 1760
2025
Q2 		– Sell
-15,570
Closed -$823K – 3212
2025
Q1 		$823K Sell
15,570
-717
-4% -$39.8K ﹤0.01% 1835
2024
Q4 		$921K Buy
+16,287
New +$900K ﹤0.01% 1850

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

HSBC Holdings's RYTM Position: Q2 2026 in Review

HSBC Holdings sold out of Rhythm Pharmaceuticals (RYTM) in Q2 2026, closing a stake of 14,307 shares — an estimated $1.22M sold.

HSBC Holdings first reported a position in RYTM in Q4 2024 and held it in 3 quarters. The position peaked at $1.22M in Q1 2026. 303 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • HSBC Holdings reported no remaining Rhythm Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • HSBC Holdings sold 14,307 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $1.22M.
  • HSBC Holdings first reported a position in Rhythm Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • HSBC Holdings's Rhythm Pharmaceuticals position peaked at $1.22M in Q1 2026.
  • 303 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.